Stock DRREDDY DR. REDDY'S LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Market Closed - Bombay S.E.
Other stock markets
 06:00:50 2024-04-26 am EDT 		5-day change 1st Jan Change
6,253 INR +0.58% Intraday chart for Dr. Reddy's Laboratories Limited +5.23% +7.85%
04:43pm Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5% MT
Apr. 25 Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.5%
MT
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
MT
Nestle India Reports Rise in Quarterly Profit, Announces JV With Dr. Reddy's Laboratories
DJ
Banking Stocks Lift Indian Equities Higher
MT
Dr. Reddy's Laboratories Names CEO-North America
MT
Dr. Reddy's Laboratories Limited Announces Executive Changes
CI
Dr. Reddy's Laboratories Limited and Nestle India Limited Enter into Joint Venture Agreement for Investment in Dr. Reddy's Nutraceuticals Limited
CI
Genentech And Dr. Reddy's Settle BPCIA Rituximab Litigation
AQ
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Oral Solution Powder in US
MT
Dr. Reddy's Laboratories Recalls Sapropterin Dihydrochloride Powder Over Potency Concerns
MT
Dr Reddy Laboratories : . Reddy’s issues voluntary nationwide recall of Sapropterin Dihyochloride Powder for Oral Solution 100 mg due to Sub-potency - Form 6-K
PU
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
MT
Dr Reddy Laboratories : Corporate_Governance_Report- March 31_2024
PU
Dr Reddy Laboratories : . Reddy's launches Condition Management programme ‘DailyBloom™ IBS’, India’s first-ever digital integrated care plan to manage Irritable Bowel Synome - Form 6-K
PU
Dr. Reddy's Labortories Launches Care Plan for IBS Patients
MT
India's Biocon developing its own version of Wegovy, clinical trial likely next year
RE
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
MT
Dr. Reddy's Laboratories Limited Receives an Order from the Commissioner of CGST,, Chandigarh
CI
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
MT
Financial, Telecoms Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Lower Tuesday
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. News Dr. Reddy's Laboratories Limited